AOD-9604 (Anti-Obesity Drug 9604) is a 16-amino-acid synthetic peptide based on residues 176-191 of the C-terminal region of human growth hormone, with the N-terminal phenylalanine replaced by tyrosine to improve stability
Tesamorelin reduces visceral adipose tissue in HIV patients
Unlike full-length growth hormone, it does not promote muscle growth or affect glucose metabolism, making it selective for fat metabolism
The 28-Day Rule Even though bacteriostatic water contains a preservative, most clinical guidelines suggest discarding a reconstituted vial after 28 days
Product Description: This compound is not approved for human or veterinary use, and must not be used for therapeutic, diagnostic, or clinical purposes
Measurable changes in fasting glucose and subjective energy typically appear within 710 days, while body composition shiftsreduced visceral adiposity and improved lean mass ratiobecome evident at 46 weeks with consistent dosing